Promore Pharma AB
PROMO SE0009947740
ICB 2010 : Health Care / Health CareSweden 171 65
SE-AB Solna Fogdevreten 2
Registration Number 556639-6809
Founded 2003
Previous Name(s):
Lipopeptide AB
Annual Performance 1
2021 | 2022 | 2023 | 2024 | 2025 |
---|---|---|---|---|
-46% | -59% | -89% | 9999% | 0% |
Annual Insiders Turnover, USD 2
1 annual and historical performance metrics are recalculated on a daily basis;
2 represents the total value of insider transactions (both buying and selling);
Insider Activity
Transactions: 21 Insiders: 4
Person | Price | Shares | Total | Published | Completed |
---|---|---|---|---|---|
Anne Dorney DIR |
0.26 SEK |
208,000 Bought |
53,528 SEK |
25/01/2024 | 22/01/2024 |
Anne Dorney DIR |
0.19 SEK |
255,000 Bought |
48,110 SEK |
22/01/2024 | 19/01/2024 |
Anne Dorney DIR |
0.17 SEK |
348,540 Bought |
57,575 SEK |
22/01/2024 | 18/01/2024 |
Anne Dorney DIR |
0.15 SEK |
348,506 Bought |
51,305 SEK |
22/01/2024 | 18/01/2024 |
Anne Dorney DIR |
0.13 SEK |
435,000 Bought |
56,463 SEK |
22/01/2024 | 17/01/2024 |
Anne Dorney DIR |
0.13 SEK |
430,000 Bought |
54,278 SEK |
22/01/2024 | 17/01/2024 |
Anne Dorney DIR |
0.11 SEK |
275,000 Bought |
30,632 SEK |
22/01/2024 | 16/01/2024 |
Anne Dorney DIR |
0.10 SEK |
110,000 Bought |
11,275 SEK |
22/01/2024 | 16/01/2024 |
Erik Magnusson CFO |
1.58 SEK |
39,800 Bought |
62,831 SEK |
01/12/2021 | 01/12/2021 |
Jonas Ekblom CEO |
2.00 SEK |
16,666 Bought |
33,332 SEK |
17/06/2021 | 17/06/2021 |